![Rodger Novak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodger Novak
Founder at
Xap Therapeutics Ltd
Profile
Rodger Novak founded CRISPR Therapeutics AG and Nabriva Therapeutics GmbH. Presently, Dr. Novak occupies the position of Chairman & President of CRISPR Therapeutics AG. In the past he occupied the position of Global Head-Anti Infectives Research & Development at Sanofi Pharma SA, Chief Operating Officer for Nabriva Therapeutics GmbH, Head-Scientific & Medical Affairs at Antibiotic Research Institute, Deputy Head-Antibiotic Research Institute at Sandoz AG, Deputy Head-Antibiotic Research Institute at Sandoz GmbH and Professor-Microbiology at Vienna Biocenter. Rodger Novak received a doctorate from Philipps University of Marburg.
Rodger Novak active positions
| Companies | Position | Start |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 2020-09-30 |
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Director/Board Member | 2013-12-31 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Director/Board Member | - |
Xap Therapeutics Ltd
 Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Founder | - |
Former positions of Rodger Novak
| Companies | Position | End |
|---|---|---|
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 2024-12-31 |
| CRISPR THERAPEUTICS AG | Chief Executive Officer | 2017-11-30 |
Sanofi AG | Corporate Officer/Principal | 2013-10-31 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 2005-11-30 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Founder | - |
Training of Rodger Novak
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
32
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Antibiotic Research Institute
 Antibiotic Research Institute Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and biotechnological drugs | Health Technology |
Sanofi AG | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vienna Biocenter
 Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Operates biology research center | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Health Technology |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
- Stock Market
- Insiders
- Rodger Novak
